Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$5.44 - $7.47 $0 - $0
0 New
0 $0
Q1 2024

Apr 30, 2024

BUY
$3.79 - $6.91 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024

BUY
$4.43 - $5.81 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023

BUY
$4.73 - $7.83 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023

BUY
$4.73 - $7.83 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023

BUY
$5.27 - $6.9 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$3.14 - $6.19 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$3.73 - $4.6 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$3.48 - $4.98 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$3.42 - $10.06 $0 - $0
0 New
0 $0

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $46.6M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.